BATE KENNETH - Insider Non-Derivative Transactions at MADRIGAL PHARMACEUTICALS, INC. (MDGL) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Jun 25, 2024, BATE KENNETH's relationship to MADRIGAL PHARMACEUTICALS, INC. (MDGL) is Director, and currently has 1,912 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other MDGL insiders.

Data Source: SEC.
BATE KENNETH - Insider Non-Derivative Transactions of MDGL Common Stock
BATE KENNETH - Insider Non-Derivative Transactions at MDGL
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Jun 26, 2024 Acquisition -- (Common Stock) 714 0 1912
Apr 3, 2024 Sell -- (Common Stock) 7 249.05 1198
Apr 3, 2024 Sell -- (Common Stock) 193 248.49 1205
Apr 3, 2024 Sell -- (Common Stock) 100 246.88 1398
Apr 3, 2024 Sell -- (Common Stock) 567 246.2 1498
Apr 3, 2024 Sell -- (Common Stock) 2080 244.97 2065
Apr 3, 2024 Sell -- (Common Stock) 7048 244.27 4145
Apr 3, 2024 Sell -- (Common Stock) 1217 243.28 11193
Apr 3, 2024 M -- (Common Stock) 11212 105.08 12410
Apr 2, 2024 Sell -- (Common Stock) 274 266.91 1198
Apr 2, 2024 Sell -- (Common Stock) 700 265.36 1472
Apr 2, 2024 Sell -- (Common Stock) 116 264.73 2172
Apr 2, 2024 Sell -- (Common Stock) 143 263.08 2288
Apr 2, 2024 Sell -- (Common Stock) 841 262.18 2431
Apr 2, 2024 Sell -- (Common Stock) 200 259.13 3272
Apr 2, 2024 Sell -- (Common Stock) 2104 258.24 3472
Apr 2, 2024 Sell -- (Common Stock) 2790 257.33 5576
Apr 2, 2024 Sell -- (Common Stock) 7411 256.49 8366
Apr 2, 2024 M -- (Common Stock) 10000 9.45 11198
Apr 2, 2024 Sell -- (Common Stock) 6698 255.62 15777
Apr 2, 2024 M -- (Common Stock) 10000 100.45 21198
Apr 2, 2024 M -- (Common Stock) 1277 105.08 22475
Jun 16, 2023 Acquisition -- (Common Stock) 1198 0 1198